Suggested Topics within your search.
Showing 421 - 440 results of 2,042 for search '"peptides"', query time: 0.07s Refine Results
  1. 421
  2. 422

    Population pharmacokinetic modeling of zavegepant, a calcitonin gene‐related peptide receptor antagonist, in healthy adults and patients with migraine by Craig M. Comisar, Jose Francis, Jim H. Hughes, Rajinder Bhardwaj, Richard Bertz, Jing Liu

    Published 2025-01-01
    “…Abstract Zavegepant (ZAVZPRET™) is a high‐affinity, selective, small‐molecule calcitonin gene‐related peptide receptor antagonist available for acute treatment of migraine in adults. …”
    Get full text
    Article
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428

    Near-Infrared Optical Imaging of Ovarian Cancer Xenografts with Novel α3-Integrin Binding Peptide “OA02” by Olulanu H. Aina, Jan Marik, Regina Gandour-Edwards, Kit S. Lam

    Published 2005-10-01
    “…One of the peptides identified from the 20% “down-substituted” focused library was the cdG-HCit-GPQc (“OA02”) peptide. …”
    Get full text
    Article
  9. 429
  10. 430

    Immunoinformatics Approach for Epitope-Based Peptide Vaccine Design and Active Site Prediction against Polyprotein of Emerging Oropouche Virus by Utpal Kumar Adhikari, Mourad Tayebi, M. Mizanur Rahman

    Published 2018-01-01
    “…Collectively, this research provides novel candidates for epitope-based peptide vaccine design against OROV.…”
    Get full text
    Article
  11. 431
  12. 432

    Screening and evaluation of novel DPP-IV inhibitory peptides in goat milk based on molecular docking and molecular dynamics simulation by Kuo Dang, Jing Lan, Yanli Wang, Daodong Pan, Lihui Du, Shikun Suo, Yali Dang, Xinchang Gao

    Published 2025-01-01
    “…Virtual screening techniques have gained much attention as a means of studying bioactive peptides. This study aimed to screen DPP-IV inhibitor peptides in goat milk after simulated digestion in vitro combined with molecular docking and dynamics simulations. …”
    Get full text
    Article
  13. 433
  14. 434

    Chronic C-Type Natriuretic Peptide Infusion Attenuates Angiotensin II-Induced Myocardial Superoxide Production and Cardiac Remodeling by Yasuhiro Izumiya, Satoshi Araki, Hiroki Usuku, Taku Rokutanda, Shinsuke Hanatani, Hisao Ogawa

    Published 2012-01-01
    “…Myocardial oxidative stress and inflammation are key mechanisms in cardiovascular remodeling. C-type natriuretic peptide (CNP) is an endothelium-derived cardioprotective factor, although its effect on cardiac superoxide generation has not been investigated in vivo. …”
    Get full text
    Article
  15. 435
  16. 436
  17. 437

    Effect of glucagon-like peptide-1 receptor agonists in osteoarthritis: A systematic review of pre-clinical and human studies by Jacinta Cheng, Tia Solomon, Mahnuma Estee, Flavia M. Cicuttini, Yuan Z. Lim

    Published 2025-03-01
    “…Objective: There is significant interest in the potential of glucagon-like peptide 1 receptor agonists (GLP-1A) to improve outcomes in osteoarthritis. …”
    Get full text
    Article
  18. 438
  19. 439
  20. 440

    Reduced Serum Glucagon Like Peptide-1 In Children with Osteoporosis of Chronic Liver Diseases: A Single Center Trial by Nashwa F. Mohamed Elmetwaly, Ola G. Behairy, Manal S. EL-Defrawy, Ola E. Seleim, Dina S. Abdelmotaleb

    Published 2025-01-01
    “…Background: Chronic liver disease (CLD) in children is associated with reduction of bone mineral density. Glucagon like peptide- 1 (GLP-1) is essential for bone metabolism and bone turnover. …”
    Get full text
    Article